GLENN SBLENDORIO Insider Trading $FOLD AMICUS THERAPEUTICS, INC.

FREE EMAIL WATCHDOG

Get free email notifications about insider trading for GLENN SBLENDORIO.

  • Your email is safe with us.
  • The service is free and you can unsubscribe at any time.

General | Insider Transactions | Monthly Overview

Get the latest insider transactions of GLENN SBLENDORIO. GLENN SBLENDORIO is President & CFO in MEDICINES CO /DE ($MDCO) and Director in AMICUS THERAPEUTICS INC ($FOLD) and CFO, SR VP FINANCE in EYETECH PHARMACEUTICALS INC ($EYET) and Director in INTERCEPT PHARMACEUTICALS INC ($ICPT) and Director in Ophthotech Corp. ($OPHT) and EVP, COO & CFO, Treasurer in Ophthotech Corp. ($OPHT) and President & CEO in IVERIC bio, Inc. ($OPHT) and President and CEO in Ophthotech Corp. ($OPHT) and President, CFO & Treasurer in Ophthotech Corp. ($OPHT) and President, CFO and Treasurer in Ophthotech Corp. ($OPHT).

GLENN SBLENDORIO in AMICUS THERAPEUTICS, INC.

Trading Symbol: FOLD
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of GLENN SBLENDORIO: Director
Holdings: 33,933 shares
Current Value: $204,277
Latest Transaction: Jun 08 2020
$FOLD Market Capitalization: $869.61M
$FOLD Previous Close: $6.02

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD

Latest Insider Trading Transactions of GLENN SBLENDORIO in AMICUS THERAPEUTICS, INC.

1 Week2 Weeks1 Month3 Months6 Months1 Year2 Years
No. of Purchases0000000
Value of Purchases ($)0000000
No. of Sales0000000
Value of Sales ($)0000000

Sentiment: All, FOLD, EYET, ICPT, OPHT, MDCO

Page:   1

DateTickerCompanyOwnerRelationship Transaction Code Cost ($) Shares Transaction Value ($) Total Shares % Holdings
Jun 08 2020FOLDAMICUS THERAPEUTIC ...SBLENDORIO GLENNDirectorOption ExerciseA12.8118,574237,93318,574
Jun 08 2020FOLDAMICUS THERAPEUTIC ...SBLENDORIO GLENNDirectorGrantA0.005,855033,93328.1 K to 33.9 K (+20.85 %)
Jul 01 2019FOLDAMICUS THERAPEUTIC ...SBLENDORIO GLENNDirectorOption ExerciseA12.0019,473233,67619,473
Jul 01 2019FOLDAMICUS THERAPEUTIC ...SBLENDORIO GLENNDirectorGrantA0.006,250028,07821.8 K to 28.1 K (+28.63 %)
Jun 11 2018FOLDAMICUS THERAPEUTIC ...SBLENDORIO GLENNDirectorOption ExerciseA16.238,912144,6428,912
Jun 11 2018FOLDAMICUS THERAPEUTIC ...SBLENDORIO GLENNDirectorGrantA0.003,08108,8955.8 K to 8.9 K (+52.99 %)
Jun 15 2017FOLDAMICUS THERAPEUTIC ...SBLENDORIO GLENNDirectorOption ExerciseA8.6016,236139,63016,236
Jun 15 2017FOLDAMICUS THERAPEUTIC ...SBLENDORIO GLENNDirectorGrantA0.005,814017,74711.9 K to 17.7 K (+48.72 %)
Jun 13 2016FOLDAMICUS THERAPEUTIC ...SBLENDORIO GLENNDirectorOption ExerciseA6.7120,000134,20020,000
Jul 15 2015FOLDAMICUS THERAPEUTIC ...SBLENDORIO GLENNDirectorOption ExerciseM10.5310,000105,3000
Jul 15 2015FOLDAMICUS THERAPEUTIC ...SBLENDORIO GLENNDirectorSellS15.0010,000150,00011,93321.9 K to 11.9 K (-45.59 %)
Jul 15 2015FOLDAMICUS THERAPEUTIC ...SBLENDORIO GLENNDirectorBuyM15.0010,000150,00021,93311.9 K to 21.9 K (+83.80 %)
Jun 12 2015FOLDAMICUS THERAPEUTIC ...SBLENDORIO GLENNDirectorOption ExerciseA13.0920,000261,80020,000
Apr 17 2015FOLDAMICUS THERAPEUTIC ...SBLENDORIO GLENNDirectorOption ExerciseM7.1510,00071,5000
Apr 17 2015FOLDAMICUS THERAPEUTIC ...SBLENDORIO GLENNDirectorOption ExerciseM7.5110,00075,1000
Apr 17 2015FOLDAMICUS THERAPEUTIC ...SBLENDORIO GLENNDirectorSellS12.5020,000250,00011,93331.9 K to 11.9 K (-62.63 %)
Apr 17 2015FOLDAMICUS THERAPEUTIC ...SBLENDORIO GLENNDirectorBuyM12.5020,000250,00031,93311.9 K to 31.9 K (+167.60 %)

Page:   1